Gecacitinib in the Treatment of Steroid-Refractory/Dependent Chronic Graf Versus Host Disease (cGVHD).
Clinical trial NCT07476872 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07476872
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-16
- Primary completion
- 2027-11-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.